Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00046449
NCT00046449
Completed
Phase 3

Prevention of Seasonal Affective Disorder

GlaxoSmithKline2 sites in 2 countriesSeptember 2002
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSeasonal Affective Disorder (SAD)
DrugsInvestigational Seasonal Affective Disorder (SAD) Drug

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Seasonal Affective Disorder (SAD)
Sponsor
GlaxoSmithKline
Locations
2
Status
Completed
Last Updated
10 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder

Registry
clinicaltrials.gov
Start Date
September 2002
End Date
June 2003
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •(Patient must meet these criteria in order to be eligible for this study.)
  • •Patient has a history of Major Depressive Disorder (MDD) with a seasonal pattern.

Exclusion Criteria

  • •(Patient cannot meet these criteria in order to be eligible for this study.)
  • •Patient has a current or past history of seizure disorder or brain injury.
  • •Patient has a history or current diagnosis of anorexia nervousa or bulimia.
  • •Patient has recurrent summer depression more frequently than winter depression.
  • •Patient has primary diagnosis of panic disorder, Obsessive Compulsive Disorder (OCD), Posttraumatic Stress Disorder (PTSD), acute distress disorder, bipolar II disorder or other psychotic disorders.
  • •Patient has initiated psychotherapy within the last 3 months.

Outcomes

Primary Outcomes

Not specified

Study Sites (2)

Loading locations...

Similar Trials

Completed
Phase 1
Seasonal Affective Depression (SAD) StudyDepressive Disorder
NCT00069459GlaxoSmithKline250
Completed
Not Applicable
Low Intensity 'Blue Light' Treatment of Seasonal Affective DisorderSeasonal Affective Disorder
NCT01149135University Medical Center Groningen22
Completed
Phase 2
Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain InjuryTraumatic Brain Injury
NCT00704379Baylor College of Medicine94
Completed
Not Applicable
Blue Enriched Versus Standard Light Treatment for Seasonal Affective Disorder(SAD)Seasonal Affective Disorder
NCT01048294University Medical Center Groningen52
Completed
Phase 3
Prevention of Seasonal Affective DisorderSeasonal Affective Disorder
NCT00046241GlaxoSmithKline300